Literature DB >> 32425437

Impact of Acute Kidney Injury and Baseline Renal Impairment on Prognosis Among Patients Undergoing Percutaneous Coronary Intervention.

Ming-Yan Jiang1.   

Abstract

BACKGROUND: Both chronic kidney disease (CKD) and acute kidney injury (AKI) are associated with adverse consequences among patients undergoing percutaneous coronary intervention (PCI). However, it remains undetermined whether the impact of CKD and post-PCI AKI are similar. We aimed to discriminate between the impact of CKD and post-PCI AKI on short- and long-term outcomes.
METHODS: This retrospective cohort study included 1,100 patients undergoing PCI at a tertiary hospital. Based on baseline kidney function, patients were categorized as having preserved or impaired renal function, defining as an estimated glomerular filtration rate (eGFR) of ≥ and < 45 ml/min/1.73 m2, respectively. Post-PCI AKI was defined as ≥ 100% relative increase between baseline and post-procedural serum creatinine.
RESULTS: Post-PCI AKI was associated with an increased risk of 90-day mortality [odds ratio (OR): 22.03, 95% confidence interval (CI): 10.36-46.88], long-term mortality [hazard ratio (HR): 6.63, 95% CI: 4.31-10.20], and composite endpoint of future end-stage renal disease (ESRD) and death (HR: 6.19, 95% CI: 4.06-9.42). Impaired kidney function at baseline was associated with an increased risk of future ESRD and composite endpoint of ESRD and death (for every 10 unit increase in eGFR, HR: 0.25, 95% CI: 0.14-0.43, and HR: 0.89, 95% CI: 0.82-0.97, respectively). The impact of post-PCI AKI outweighed that of impaired baseline renal function on short- and long-term prognosis. Patients with impaired baseline renal function who developed AKI following PCI had the worst prognosis.
CONCLUSIONS: Both post-PCI AKI and CKD were associated with a poor prognosis. Post-PCI AKI was more important than baseline renal function to predict long-term mortality and composite outcomes. The systemic pathophysiologic change accompanying AKI, rather than renal function per se, may play a crucial role.

Entities:  

Keywords:  Acute kidney injury; Chronic kidney disease; End-stage renal disease; Mortality; Percutaneous coronary intervention

Year:  2020        PMID: 32425437      PMCID: PMC7220960          DOI: 10.6515/ACS.202005_36(3).20190920A

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


  27 in total

1.  Effects of chronic kidney disease and post-angiographic acute kidney injury on long-term prognosis after coronary artery angiography.

Authors:  Tomonori Kimura; Yoshitsugu Obi; Keiko Yasuda; Ko-ichi Sasaki; Yoshihiro Takeda; Yoshiyuki Nagai; Enyu Imai; Hiromi Rakugi; Yoshitaka Isaka; Terumasa Hayashi
Journal:  Nephrol Dial Transplant       Date:  2010-10-12       Impact factor: 5.992

2.  Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry.

Authors:  Thomas T Tsai; Uptal D Patel; Tara I Chang; Kevin F Kennedy; Frederick A Masoudi; Michael E Matheny; Mikhail Kosiborod; Amit P Amin; John C Messenger; John S Rumsfeld; John A Spertus
Journal:  JACC Cardiovasc Interv       Date:  2014-01       Impact factor: 11.195

3.  Effect of Contrast-Induced Nephropathy on the Long-Term Outcome of Patients with Non-ST Segment Elevation Myocardial Infarction.

Authors:  Burak Turan; Ayhan Erkol; Mehmet Gül; Uğur Fındıkçıoğlu; İsmail Erden
Journal:  Cardiorenal Med       Date:  2015-02-28       Impact factor: 2.041

4.  Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy.

Authors:  Amar Narula; Roxana Mehran; Giora Weisz; George D Dangas; Jennifer Yu; Philippe Généreux; Eugenia Nikolsky; Sorin J Brener; Bernhard Witzenbichler; Giulio Guagliumi; Avery E Clark; Martin Fahy; Ke Xu; Bruce R Brodie; Gregg W Stone
Journal:  Eur Heart J       Date:  2014-03-06       Impact factor: 29.983

5.  SYNTAX Score of Infarct-Related Artery Other Than the Number of Coronary Balloon Inflations and Deflations as an Independent Predictor of Contrast-Induced Acute Kidney Injury in Patients with ST-Segment Elevation Myocardial Infarction.

Authors:  Cheng-Wei Liu; Pen-Chih Liao; Kuo-Chin Chen; Jung-Cheng Hsu; Chung-Ming Tu; Yen-Wen Wu; Ai-Hsien Li; Shin-Rong Ke; Jiunn-Lee Lin
Journal:  Acta Cardiol Sin       Date:  2017-07       Impact factor: 2.672

6.  Associations of increases in serum creatinine with mortality and length of hospital stay after coronary angiography.

Authors:  Steven D Weisbord; Huanyu Chen; Roslyn A Stone; Kevin E Kip; Michael J Fine; Melissa I Saul; Paul M Palevsky
Journal:  J Am Soc Nephrol       Date:  2006-08-23       Impact factor: 10.121

7.  Associations between acute kidney injury and cardiovascular and renal outcomes after coronary angiography.

Authors:  Matthew T James; William A Ghali; Merril L Knudtson; Pietro Ravani; Marcello Tonelli; Peter Faris; Neesh Pannu; Braden J Manns; Scott W Klarenbach; Brenda R Hemmelgarn
Journal:  Circulation       Date:  2011-01-17       Impact factor: 29.690

8.  PROGRESSION OF CHRONIC KIDNEY DISEASE AFTER ACUTE KIDNEY INJURY.

Authors:  Prasad Devarajan; John Lynn Jefferies
Journal:  Prog Pediatr Cardiol       Date:  2016-06

Review 9.  Long-term prognosis after acute kidney injury (AKI): what is the role of baseline kidney function and recovery? A systematic review.

Authors:  Simon Sawhney; Mhairi Mitchell; Angharad Marks; Nick Fluck; Corrinda Black
Journal:  BMJ Open       Date:  2015-01-06       Impact factor: 2.692

10.  TIMI and GRACE Risk Scores Predict Both Short-Term and Long-Term Outcomes in Chinese Patients with Acute Myocardial Infarction.

Authors:  Ying-Hwa Chen; Shao-Sung Huang; Shing-Jong Lin
Journal:  Acta Cardiol Sin       Date:  2018-01       Impact factor: 2.672

View more
  1 in total

1.  Procedure-Related Access Site Pain Multimodal Management following Percutaneous Cardiac Intervention: A Randomized Control Trial.

Authors:  Liuda Brogiene; Aiste Urbonaite; Giedre Baksyte; Andrius Macas
Journal:  Pain Res Manag       Date:  2022-01-24       Impact factor: 3.037

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.